01 1Centaur Pharmaceuticals
01 1LEVOMILNACIPRAN HYDROCHLORIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-05-17
Pay. Date : 2017-04-27
DMF Number : 31699
Submission : 2017-04-28
Status : Active
Type : II
20
Centaur Pharmaceuticals Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVOMILNACIPRAN HYDROCHLORIDE, with a corresponding US DMF Number 31699.
Remarkably, this DMF maintains an Active status since its submission on April 28, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 17, 2017, and payment made on April 27, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
